NCT04028856View on ClinicalTrials.gov

Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Chronic Hepatitis B
Interventions
DRUG

interferon

Chronic hepatitis B patients were treated with interferon for 48 weeks

Trial Locations (1)

100015

liver disease center, Beijing Ditan Hospital, Beijing

All Listed Sponsors
lead

Beijing Ditan Hospital

OTHER

NCT04028856 - Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B | Biotech Hunter | Biotech Hunter